Formycon AG (ETR:FYB)
18.90
+0.06 (0.32%)
Oct 26, 2026, 5:35 PM CET
Formycon AG Employees
Formycon AG had 196 employees as of June 30, 2026. The number of employees decreased by 7 or 3.45% since the number was reported on December 31, 2025. That makes Formycon AG the 26,972nd largest employer in the world and 396th in Germany.
Employees
196
Change
-7
Growth
-3.45%
Revenue / Employee
€312,459
Profits / Employee
€128,224
Market Cap
334.02M
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 196 | -7 | -3.45% | 196 | 0 |
| Dec 31, 2025 | 203 | -47 | -18.80% | 203 | 0 |
| Dec 31, 2024 | 250 | 12 | 5.04% | 250 | 0 |
| Dec 31, 2023 | 238 | 33 | 16.10% | 238 | 0 |
| Dec 31, 2022 | 205 | 34 | 19.88% | 205 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| MEDICLIN Aktiengesellschaft | 7,048 |
| Evotec SE | 4,461 |
| Stratec SE | 1,383 |
| Eckert & Ziegler SE | 1,105 |
Formycon AG News
- 3 days ago - EQS-AFR: Formycon AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 5 days ago - EQS-News: Formycon and Biocelys Combine Complementary Development and Manufacturing Expertise in New Biosimilar Project FYB286 - Wallstreet:Online
- 6 days ago - EQS-RPT: Formycon AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 13 days ago - USFDA accepts biosimilar application of Zydus and German firm for Keytruda - The Times of India
- 13 days ago - FDA Accepts BLA For Formycon And Zydus' Keytruda Biosimilar FYB206 ;Shares Rise - Nasdaq
- 13 days ago - EQS-News: Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted for Review by FDA - Wallstreet:Online
- 20 days ago - EQS-News: Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy - Wallstreet:Online
- 4 weeks ago - EQS-News: Formycon sets Benchmark in Biosimilar Development: Scientific Foundation of the innovative Development Program for FYB206 published in the Journal BioDrugs - Wallstreet:Online